NCT04115475View on ClinicalTrials.gov

New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
Muscular DiseasesSpinal Muscular Atrophy
Interventions
DEVICE

Multispectral Optoacoustic Tomography (MSOT)

Non-invasive transcutaneous imaging of subcellular muscle components

Trial Locations (1)

91054

Department of Pediatrics and Adolescent Medicine, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER

NCT04115475 - New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy | Biotech Hunter | Biotech Hunter